Ocular Therapeutix OCUL
NASDAQ OCUL
$6.48 -0.17 (-2.56%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Short-Term Debt repayments (2014 - 2017)

Updated

Ocular Therapeutix's Short-Term Debt repayments was $2 million in FY2023.

Analysis

Ocular Therapeutix (OCUL) Short-Term Debt repayments (2014 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 6.45 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Ocular Therapeutix 1.45 Bn -895.10 Mn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 197,000.00
Jun 30, 2017 197,000.00
Mar 31, 2017 197,000.00
Dec 31, 2016 130,000.00
Jun 30, 2016 195,000.00
Mar 31, 2016 194,000.00
Dec 31, 2015 222,000.00
Sep 30, 2015 198,000.00
Jun 30, 2015 171,000.00
Mar 31, 2015 171,000.00
Dec 31, 2014 171,000.00
API Access

Ocular Therapeutix Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=OCUL&period=max&api_key=YOUR_API_KEY